Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism

Diabetes and Metabolism

Volumn 24, Issue 6, 1998, Pages 490-495

  Fredenrich, A ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Apolipoprotein CIII; Apolipoprotein E; Atherosclerosis; Lipoproteins; Non insulin dependent diabetes mellitus

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN C3; COLESTIPOL; DRUG RECEPTOR; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; NICOTINIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; PROTEIN POLYMORPHISM; REVIEW; STRUCTURE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANTILIPEMIC AGENTS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; HUMANS; LIPOPROTEINS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES;

EID: 0032418940     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Mahley RW, Innerarity TL, Rail SC Jr, Weisgraber KH. Plasma lipoproteins : apolipoprotein structure and function. J Lipid Res, 1984, 25, 1277-1294.
2. Mahley RW. ApoE : cholesterol transport protein with expanding role in cell biology. Science, 1988, 240, 622-630.
3. Yamamoto K, Bujo H. Close encounters with ApoE receptors. Curr Op Lipidol, 1996, 7, 298-302.
4. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest. 1993, 91, 748-758.
5. Brewer HB Jr, Shulman R, Herbert P, Ronan R, Wehrly K. The complete aminoacid sequence of alanine apolipoprotein (apo C-III), an apolipoprotein from human plasma very low density lipoproteins. J Biol Client, 1974, 249, 4975-4984.
6. Mao SJT, Bhatnagar PK, Gotto AM, Sparrow JT. Immunochemistry of human VLDL : apolipoprotein CIII. Biochemistry, 1980, 19, 315-320.
7. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-l gene : relation to hypertriglyceridaemia. Lancet, 1983, 1, 444-446.
8. Tas S. Strong association of a single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-CIII gene with hypertrig-lyceridemia in Arabs. Clin Chem, 1989, 35, 256-259.
9. Zeng Q, Dammerman M, Takada Y, Matsunaga A; Breslow JL, Sasaki J. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet, 1995, 95, 361-375.
10. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci USA, 1993, 90, 4562-4566.
11. Xu CF, Talmud P, Humphries S. Three new polymorphisms of the apoAI-CIII-AIV gene cluster. Mol Cell Probes, 1994, 8, 331-332.
12. Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. Polymorphic markers in apolipoprotein CIII gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol, 1996, 16, 941-947.
13. Hegele RA, Connelly PW, Hanley AJG, Sun F, Harris SB, Zinman B. Common genomic variation in the ApoC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb Vasc Biol, 1997, 17, 2753-2758.